Evaluation of the diagnostic performance of YiDiXie™ tests in urothelial carcinoma
YiDiXie™ tests showed considerable validity in the diagnosis of urothelial carcinoma with significantly different levels of sensitivity and specificity. They have significant diagnostic value in urothelial carcinoma, improving the diagnosis of upper urinary tract epithelial tumors and potentially providing an alternative to cystoscopy in combination with CT or ultrasound. Clinical study registration number ChiCTR2200066840.
Authors
- Shengjie Lin (ORCID: https://orcid.org/0000-0002-1352-321X)
- Zhengping Zhao
- Wenkang Chen (ORCID: https://orcid.org/0000-0001-7326-2595)
- Chen Sun (ORCID: https://orcid.org/0009-0006-9354-9888)
- Yongqing Lai (ORCID: https://orcid.org/0000-0002-5353-9355)
- Yingqi Li (ORCID: https://orcid.org/0009-0007-6169-405X)
- Xionghui Wu
- Huimei Zhou
- Zhenjian Ge
Institutions
- BGI Group (China) (CN)
- Anhui Medical University (CN)
- Hong Kong University of Science and Technology (HK)
- Shantou University (CN)
- Shantou University Medical College (CN)
- Peking University Shenzhen Hospital (CN)
- Shenzhen University Health Science Center (CN)
- Shenzhen Institute for Drug Control (CN)
- Shenzhen Pingle Orthopedic Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1186/s40001-025-03369-7
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking University